HomeInsights52 Week Low Stocks

Alembic Pharmaceuticals Ltd 52 Week Low

Alembic Pharmaceuticals Ltd 52 Week Low

stocks purchased

₹ 0.1 Cr

Volume transacted

stocks purchased

1.0 K

stocks traded

Last Updated time: 05 Nov 10:21 AM

Image

Alembic Pharmaceuticals Ltd

NSE: APLLTD

YEARLOW

710.5

Last updated on: Nov 04, 2024

Key Highlights

  • The 52 Week Low of Alembic Pharmaceuticals Ltd is ₹ 710.5 as of 04 Nov 24.

Company Fundamentals for Alembic Pharmaceuticals Ltd

No data available

Market price Over Time

1M

1Y

3Y

5Y

Monitoring Alembic Pharmaceuticals Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date
leftPriceleft
04 Nov 20241124.65
01 Nov 20241121.4
31 Oct 20241128.75
30 Oct 20241083.3
29 Oct 20241061.6
28 Oct 20241074.2
25 Oct 20241068.5
24 Oct 20241066.8
23 Oct 20241085.35
22 Oct 20241090.7

Asset Value vs Market Value of Alembic Pharmaceuticals Ltd

Market Value

0

Asset Value

0

* All values are in Rupees

Historical Revenue of Alembic Pharmaceuticals Ltd

No data available

* All values are in crore

Historical Net Profit of Alembic Pharmaceuticals Ltd

No data available

* All values are in crore

Alembic Pharmaceuticals Ltd News Hub

News

Alembic Pharma gets USFDA nod for hypertension treatment drug

The said drug is therapeutically equivalent to the reference listed drug product (RLD), Di...

Read more

21 Oct 202411:23

News

Alembic Pharmaceuticals to discuss results

Alembic Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 7 ...

Read more

18 Oct 202417:20

News

Alembic Pharma's oncology formulations unit successfully completes USFDA inspection

Alembic Pharmaceuticals has successfully completed the United States Food and Drug Adminis...

Read more

09 Oct 202409:16

News

Alembic Pharma rises after oncology facility completes US FDA audit with 'zero' observations

The US FDA had conducted an inspection at the company's oncology (injectable and oral soli...

Read more

09 Oct 202409:21

News

Alembic Pharma gets US FDA nod for antihistamine Alcaftadine ophthalmic solution

The approved ANDA is therapeutically equivalent to the reference listed drug product (RLD)...

Read more

04 Oct 202409:29

News

Alembic Pharma receives USFDA approval for Lamotrigine Extended-Release Tablets

Alembic Pharmaceuticals has received final approval from the US Food & Drug Administration...

Read more

03 Oct 202409:23

Document

Annual Reports

N/A

dropdown
download

Credit Ratings

N/A

dropdown
download

Concalls

FAQs for 52 Week Low of Alembic Pharmaceuticals Ltd

Why is it important to track the 52-week low of Alembic Pharmaceuticals Ltd stocks?

Investors should monitor the 52-week low of Alembic Pharmaceuticals Ltd stocks regularly to stay informed about significant price changes and assess the stock's performance over time. Frequent monitoring will help traders identify trends and make timely decisions.

What factors can lead to Alembic Pharmaceuticals Ltd stocks hitting a 52-week low?

Factors leading to Alembic Pharmaceuticals Ltd stocks hitting a 52-week low may include poor fiscal results, negative industry trends, macroeconomic issues, or management changes. Other factors such as market volatility and broader economic downturns can also contribute to a 52-week low.

Should investors buy Alembic Pharmaceuticals Ltd stocks when they hit a 52-week low?

Buying Alembic Pharmaceuticals Ltd stocks at a 52-week low can offer a potential bargain, however, it is crucial to evaluate the reasons behind the stock price drop and ensure there is no underlying fundamental issue. Investors should consider the company's long-term prospects before making a buying decision.

How often should investors monitor the 52-week low of Alembic Pharmaceuticals Ltd stocks?

Investors should monitor the 52-week low of Alembic Pharmaceuticals Ltd stocks regularly to stay informed about significant price changes and assess the stock's performance over time, which will help them identify trends and make timely decisions.

How can an investor assess the risk of buying Alembic Pharmaceuticals Ltd stock at their 52-week low?

An investor can analyze the reasons for the Alembic Pharmaceuticals Ltd stock price drop, evaluate the company’s fundamentals, and consider market conditions. Investors should also review the stock’s historical performance and any potential recovery indicators.

Should investors consider the overall market trend when evaluating Alembic Pharmaceuticals Ltd stocks at their 52-week low?

Certainly, considering the overall market trend when evaluating Alembic Pharmaceuticals Ltd stocks at their 52-week low is significant as it provides context for the stock’s performance and potential future movements. A declining market trend may influence Alembic Pharmaceuticals Ltd stock performance, impacting the timing and potential of the investment.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
50yearstrust

Unlimited trading at just

Rs. 399

Rs. 199*